National Menopause and Perimenopause Awareness Campaign

June 3, 2026

The Australian Government has launched the National Menopause and Perimenopause Awareness Campaign to improve access to reliable information and support for women aged 35 and over who are going through this life stage.

Information and resources are now available for health professionals on the campaign website, health.gov.au/perimenopause.

The website brings together evidence-based information, practical resources and personal stories to help build understanding and support informed conversations between women and their health professionals.

Resources for health professionals include:

  • A dedicated webpage for health professionals with links to best practice guides, and information on professional development, training, health assessments, and symptom management
  • A poster for display in practices to encourage patients to discuss potential symptoms during consultations
  • A brochure about menopause and perimenopause, including common symptoms, and management and support options available
  • A symptom checklist that patients can bring to appointments to help identify symptoms and guide discussions with their health professional.

Additional resources will be released over the coming months, with updates available on the website.

For more information, visit health.gov.au/perimenopause.

Latest news

October 1, 2026
From 1 October 2026, COVID-19 vaccines will be funded under the National Immunisation Program (NIP), replacing the National COVID-19 Vaccine Program (NCVP) that was established during Australia’s response to the COVID-19 pandemic.
September 30, 2026
SEMPHN's 2026 Stakeholder Survey has found stakeholder experience improved across almost every measure, with stakeholders continuing to identify responsive staff, practical support and collaborative relationships as key strengths.
September 30, 2026
The Australian Government Department of Health, Disability and Ageing has opened two competitive national grant opportunities aimed at reducing the harms associated with Alcohol and Other Drugs (AOD) use and improving treatment access and outcomes.